EP07.05-11 Efficacy and Safety of Osimertinib Therapy in High-Risk Stage I EGFRm NSCLC after R0 Resection(OSTAR): A Prospective, Single-Arm Study
- 31 October 2023
- journal article
- abstracts
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 18 (11) , S562